Conference abstract · 2018
Conference abstractPublished 2018
Functional cure for HIV
Paris Descartes University, France
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
While current antiretroviral treatment regimens have been extremely effective, issues of associated toxicity, cost and resistance remain. There is a need for novel approaches and antiretroviral compounds to complement the existing therapy and for developing new strategies for inhibition of HIV infection. Transcription from the HIV promoter in the viral long terminal repeat is regulated by the combined activity of the host transcription machinery and the viral transactivator Tat protein. Recently, the Tat inhibitor didehydro-cortistatin (dCA) has been reported to prevent viral reactivation from latent reservoirs, resulting in a permanent state of latency or block-and-lock that could eventually culminate in a functional cure of HIV (Mousseau et al., 2015). When introduced to humanized mice models of HIV-1 infection, dCA stops the virus’s production, activation, and the replenishment of other infected cells that would contribute to the spread and growth of HIV (Kessing et al., 2017), this work demonstrated the potential of block-and-lock cure strategies. We have discovered that spironolactone (SP) - an antagonist of aldosterone - specifically inhibits HIV infection of permissive T cells and reactivation of latently infected T cells (Lacombe et al., 2016). SP-induced inhibition is mediated by blocking the Tat-dependent transcription of HIV-1 and HIV-2 and the reactivation of transcription from latent HIV-1 promoters in latently infected T cells. SP offers the advantages of being cheap and acting both in permissive cells as well as in reservoirs where the virus persists despite antiretroviral therapy. Finally, only HIV transcriptional inhibitors like dCA and SP that prevent infected cells from making viruses, stop the side effects of low-level virus production.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 4 Jan 2017
A case of a functionally cured HIV patient who took herbal medicine
Perspective · 29 Jul 2025
HIV-1 Research: Cure, Resistance, and Novel Therapies
Article · 30 Jun 2025
Eliminating HIV-1 Reservoirs: Diverse Cure Strategies
Article · 29 Apr 2025
HIV-1: T Cell Reprogramming, Latency, Cure
More from this journal
The newest in Journal of Virology & Antiviral Research.
Commentary · 19 Jun 2025
A Detailed Overview of Johne’s Disease: From Pathogenesis to Prevention and Control
Perspective · 19 Jun 2025
A Global Perspective on Brucellosis: Understanding the Disease and Diagnosis
Commentary · 19 Jun 2025
Understanding Bacterial Necrosis in Plants: Pathogenesis and Management Strategies
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Virology & Antiviral Research
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Berta Cecilia Ramirez”

